LOS ANGELES — A new dissolvable vitamin supplement combining vitamin D3 and K2 (MK-7) has entered the market, promising to revolutionize how consumers support bone density and cardiovascular health. The product utilizes proprietary rapid-dissolve technology that allows for absorption through oral mucosa without water.
The formulation capitalizes on the complementary biological functions of these two fat-soluble vitamins. Vitamin D3 enhances calcium absorption in the gastrointestinal tract, while vitamin K2 activates proteins that direct calcium deposition to skeletal tissue rather than soft tissues.
Clinical research suggests this combination may provide three primary benefits:
The dissolvable tablet format represents a technological advancement in supplement delivery. Unlike traditional capsules or tablets that require water and full gastrointestinal transit, these microtablets dissolve rapidly in the oral cavity, allowing for:
The manufacturer reports that production occurs in cGMP-certified facilities with third-party testing for purity and potency. The formulation excludes common allergens including gluten, dairy, soy, and artificial additives.
Medical professionals note that while such supplements may benefit certain populations, individual needs vary based on factors like:
The typical suggested dosage ranges between 1,000–5,000 IU of vitamin D3 paired with 90–200 mcg of vitamin K2 (MK-7 form), though optimal dosing should be determined through healthcare provider consultation.
Research indicates vitamin D3-K2 combinations may be particularly relevant for:
While the dissolvable format offers convenience advantages, experts emphasize that supplements should complement rather than replace a nutrient-rich diet and other healthy lifestyle practices.